Vape residue may harm unborn babies, mouse study suggests
Exposure to vape and e-cigarette residue on surfaces while pregnant could put unborn babies at risk of immune system damage, new research suggests.
Medical Xpress
Research reveals mechanism of effector-triggered immunity
A pair of studies examining immune response in C. elegans reveal broad implications for understanding pathogen detection in higher animals and the evolutionary origins of immunity itself.
‘Undetectable’ HIV patients could hold key to treatments
A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.
Study finds asthma rates lower in children who received only breast milk at birth hospital
Infants who were exclusively fed breast milk during their hospitalization at birth were 22% less likely to develop asthma in early childhood, according to research presented during the American Academy of Pediatrics 2024 National Conference & Exhibitio…
Nanobodies help decode the central mechanism of inflammation
The formation of pores by a particular protein, gasdermin D, plays a key role in inflammatory reactions. During its activation, an inhibitory part is split off. More than 30 of the remaining protein fragments then combine to form large pores in the cel…
Researchers discover new bacterium that causes gut immunodeficiency
Cleveland Clinic researchers have discovered a new bacterium that weakens the immune system in the gut, potentially contributing to certain inflammatory and infectious gut diseases.
Metabolic reprogramming of T cells may enhance checkpoint inhibitor therapy
Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune checkpoint inhibitor therapy, according to a preclinical study led by researchers at Weill Cornell Medicine. The findings sugges…
Newly identified ‘compound B’ holds promise as better immune booster against cancer, chronic diseases
A team of University of Alberta researchers has created a molecular compound that activates the immune system and shows promise for becoming an effective and versatile treatment for cancer and chronic infections.
Unexpected immune response may hold key to long-term cancer remission
Results from a preclinical study in mice led by EPFL, and a collaborative clinical study in patients show that the type 2 immune response—associated with parasitic infection and thought to play a negative role in cancer immunity—is positively correlate…
Scientists develop CAR-T cells to target glioblastoma while sparing healthy tissue
Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue.